Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998Experimental and Clinical Psychopharmacology

Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJed E. RoseDuke UniversityFBFrédérique M. BehmRose Research Center (United States)EWEric C. WestmanDuke University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rose et al. (1998) studied this question.

synapsesocial.com/papers/6a8abbf60f137e402b33a8bbhttps://doi.org/10.1037//1064-1297.6.3.331
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers1993 · 235 citations
  2. 2Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone1994 · 251 citations
  3. 3Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.1993 · 173 citations